The role of the Government and the Therapeutic Goods Administration (TGA) regarding medical devices, particularly Poly Implant Prothese (PIP) breast implants
Submissions received by the Committee
PLEASE NOTE: SUBMISSIONS HAVE NOW CLOSED
Sub No.
Additional Information Received
1 | Response to adverse comment raised in submissions #7, #46, #47 and #48 from Dr Daniel Fleming, received 8 May 2012(PDF 3647KB) |
Answers to Questions on Notice
1 | Answers to Questions on Notice from Tindall Gask Bentley, received 17 May 2012(PDF 4103KB) |
2 | Answers to Questions on Notice from Australian Society of Plastic Surgeons, received 18 May 2012(PDF 4511KB) |
3 | Answers to Questions on Notice from Department of Health and Ageing, received 23 May 2012(PDF 222KB) |
4 | Answers to Questions on Notice from the Australian College of Cosmetic Surgery, received 22 May 2012(PDF 74KB) |
5 | Answers to Questions on Notice from the Therapeutic Goods Administration, received 29 May 2012(PDF 35KB) |
For further information, contact: Committee Secretary
Senate Standing Committees on Community Affairs
PO Box 6100
Parliament House
Canberra ACT 2600
Australia